Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

OBJECTIVES: This double-blind trial evaluated the efficacy and safety of abatacept or infliximab vs placebo. The primary objective of this study was to evaluate the mean change from baseline in Disease Activity Score (based on erythrocyte sedimentation rates; DAS28 (ESR)) for the abatacept vs placeb...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schiff, M, Keiserman, M, Codding, C, Songcharoen, S, Berman, A, Nayiager, S, Saldate, C, Li, T, Aranda, R, Becker, J-C, Lin, C, Cornet, P L N, Dougados, M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2008
Assuntos:
Extended Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2564802/
https://ncbi.nlm.nih.gov/pubmed/18055472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.080002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados